Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

They’ve survived near-death diagnoses, endured multiple organ transplants, and fought back from physical collapse. Now, Omar ...

XORTX Therapeutics Inc. ("XORTX” or the "Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical ...

My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is so confusing. I have early Alzheimer's and have trouble organizing my ...

Natural sweeteners like honey or maple syrup, used sparingly, could be a better choice for those worried about kidney health.

A new type of drug, known as an anti-necrotic, could be the first drug ever approved to treat aging itself. The drug, which ...

An unnamed individual in Maricopa County, Arizona, was diagnosed with the deadly virus, which is becoming more prevalent in ...

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), ...

Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the best high-return penny stocks to buy now. On July 14, 2025, Akebia ...

ProKidney Corp. (NASDAQ:PROK) is a late-stage biotechnology company focused on developing a cell therapy called rilparencel ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...